![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ADDEX-ORTHO-McNEIL TIE-UP TO DEVELOP TREATMENTS FOR ANXIETY, DEPRESSION & AD
ADDEX-ORTHO-McNEIL TIE-UP TO DEVELOP TREATMENTS FOR ANXIETY, DEPRESSION & AD
Addex Pharmaceuticals has entered an exclusive worldwide research collaboration and license agreement with Ortho-McNeil Pharmaceutical, a Johnson & Johnson company, to discover, develop and commercialize novel compounds modulating allosterically G-Protein Coupled Receptors for the treatment of anxiety, depression, schizophrenia and Alzheimer's disease.
PharmaBiz (http://www.pharmabiz.com/article/detnews.asp?articleid=25738§ionid=)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct